IL130464A - New aqueous pharmaceutical preparations used in the manufacture of watering cans that do not contain gas - Google Patents

New aqueous pharmaceutical preparations used in the manufacture of watering cans that do not contain gas

Info

Publication number
IL130464A
IL130464A IL13046497A IL13046497A IL130464A IL 130464 A IL130464 A IL 130464A IL 13046497 A IL13046497 A IL 13046497A IL 13046497 A IL13046497 A IL 13046497A IL 130464 A IL130464 A IL 130464A
Authority
IL
Israel
Prior art keywords
use according
pharmaceutical preparation
active ingredient
ethanol
complexing agent
Prior art date
Application number
IL13046497A
Other languages
English (en)
Hebrew (he)
Other versions
IL130464A0 (en
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7815979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL130464(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL130464A0 publication Critical patent/IL130464A0/xx
Publication of IL130464A publication Critical patent/IL130464A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
IL13046497A 1996-12-20 1997-12-16 New aqueous pharmaceutical preparations used in the manufacture of watering cans that do not contain gas IL130464A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19653969A DE19653969A1 (de) 1996-12-20 1996-12-20 Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
PCT/EP1997/007062 WO1998027959A2 (fr) 1996-12-20 1997-12-16 Nouvelles preparations medicamenteuses aqueuses pour la production d'aerosols depourvus de gaz propulseur

Publications (2)

Publication Number Publication Date
IL130464A0 IL130464A0 (en) 2000-06-01
IL130464A true IL130464A (en) 2004-12-15

Family

ID=7815979

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13046497A IL130464A (en) 1996-12-20 1997-12-16 New aqueous pharmaceutical preparations used in the manufacture of watering cans that do not contain gas

Country Status (39)

Country Link
US (3) US20010008632A1 (fr)
EP (2) EP1230916A3 (fr)
JP (1) JP4659160B2 (fr)
KR (1) KR100496723B1 (fr)
CN (1) CN1097455C (fr)
AR (1) AR008721A1 (fr)
AT (1) ATE235887T1 (fr)
AU (1) AU740543B2 (fr)
BG (1) BG64433B1 (fr)
BR (1) BRPI9713596C1 (fr)
CA (1) CA2275392C (fr)
CO (1) CO4920211A1 (fr)
DE (2) DE19653969A1 (fr)
DK (1) DK0946146T3 (fr)
EE (1) EE03949B1 (fr)
EG (1) EG23981A (fr)
ES (1) ES2196388T3 (fr)
HK (1) HK1022846A1 (fr)
HR (1) HRP970694B1 (fr)
HU (2) HU227012B1 (fr)
ID (1) ID22481A (fr)
IL (1) IL130464A (fr)
MY (1) MY124547A (fr)
NO (1) NO320652B1 (fr)
NZ (1) NZ336825A (fr)
PE (1) PE32899A1 (fr)
PL (1) PL189511B1 (fr)
PT (1) PT946146E (fr)
RS (1) RS49803B (fr)
RU (1) RU2219906C2 (fr)
SA (1) SA97180756B1 (fr)
SI (1) SI0946146T1 (fr)
SK (1) SK282910B6 (fr)
TR (1) TR199901408T2 (fr)
TW (1) TW438605B (fr)
UA (1) UA64736C2 (fr)
UY (1) UY24813A1 (fr)
WO (1) WO1998027959A2 (fr)
ZA (1) ZA9711370B (fr)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
DE19808295A1 (de) 1998-02-27 1999-11-11 Boehringer Ingelheim Int Behälter für eine medizinische Flüssigkeit
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
DE19940713A1 (de) 1999-02-23 2001-03-01 Boehringer Ingelheim Int Kartusche für eine Flüssigkeit
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP2004509920A (ja) * 2000-09-29 2004-04-02 ボード　オブ　トラスティーズ　オペレーティング　ミシガン　ステート　ユニヴァーシティ カテコールアミン医薬組成物および方法
UA78690C2 (uk) * 2000-10-31 2007-04-25 Boehringer Ingelheim Pharma Лікарська композиція для інгаляційного застосування у вигляді розчину із сіллю тіотропію
CA2427583C (fr) * 2000-10-31 2008-02-12 Karin Drechsel Formulation d'une solution d'inhalation contenant un sel de tiotropium
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
DE10136555A1 (de) 2001-07-27 2003-02-13 Boehringer Ingelheim Int Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren
US7652030B2 (en) * 2001-09-18 2010-01-26 Nycomed Danmark Aps Compositions for treatment of common cold
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
NZ550304A (en) * 2001-10-26 2008-05-30 Dey L P An antimicrobial preservative-free albuterol inhalation solution for the relief of bronchospasm in children with asthma
AU3297402A (en) * 2001-10-26 2003-10-30 Dey, L.P. An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
DE10216036A1 (de) * 2002-04-11 2003-10-23 Boehringer Ingelheim Pharma Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt
US20050220720A1 (en) * 2002-05-02 2005-10-06 David Edwards Formulations limiting spread of pulmonary infections
WO2003092654A1 (fr) 2002-05-02 2003-11-13 President And Fellows Of Harvard College Formulations limitant l'extension d'infections pulmonaires
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
CA2495275C (fr) * 2002-08-14 2012-04-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Formulation aerosol pour l'inhalation contenant un anticholinergique
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US20050107417A1 (en) * 2003-07-28 2005-05-19 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a betamimetic
US20050042176A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a novel anticholinergic and a steroid
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US20050059643A1 (en) * 2003-08-05 2005-03-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising a steroid and a betamimetic
DE102004001451A1 (de) * 2004-01-08 2005-08-11 Boehringer Ingelheim International Gmbh Vorrichtung zum Haltern eines fluidischen Bauteiles
US20050203088A1 (en) * 2004-01-09 2005-09-15 Boehringer Ingelheim International Gmbh Medicament combinations based on scopine- or tropene acid esters with EGFR-kinase inhibitors
US20050207983A1 (en) * 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050256115A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta-agonists
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
CN1997900B (zh) 2004-05-25 2010-10-13 埃内尔迪斯特里布齐恩公司 用于检测任意未知相电压相对于参考相电压的相配线的方法和装置
WO2005123064A1 (fr) * 2004-06-10 2005-12-29 Board Of Trustees Of Michigan State University Inhalateur de complements adrenergiques comprenant des composes tels que ascorbates, tocopherols ou chelateurs d'acide polycarboxylique
US8627821B2 (en) * 2005-01-10 2014-01-14 Pulmatrix, Inc. Method and device for decreasing contamination
EP2308469A1 (fr) * 2005-05-18 2011-04-13 Pulmatrix, Inc. Formulations pour la modification de propriétés biophysiques des muqueuses
ES2530991T3 (es) 2005-08-15 2015-03-09 Boehringer Ingelheim Int Procedimiento para la obtención de betamiméticos
AU2006311060A1 (en) * 2005-11-09 2007-05-18 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
US20100144784A1 (en) * 2006-05-19 2010-06-10 Boehringer Ingelheim International Gmbh Aerosol formulation
JP5317961B2 (ja) * 2006-05-19 2013-10-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 推進剤を含まないイプラトロピウムブロマイド及びサルブタモールスルフェート含有吸入エアロゾル製剤
DE102006023756A1 (de) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
EP2207589A2 (fr) * 2007-09-13 2010-07-21 Medtronic, Inc. Dérivation électrique médical avec éléments conducteurs gainés
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2093219A1 (fr) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Forme de sel à énantiomère pur et cristalline d'un bêtamimétique et son utilisation comme médicament
EP2662472B1 (fr) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Procédé de revêtement d'une surface d'un composant
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2504052B1 (fr) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Nébuliseur
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (fr) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nébuliseur
JP5877201B2 (ja) 2010-08-30 2016-03-02 パルマトリックス，インコーポレイテッド 肺疾患を治療するための乾燥粉末製剤および方法
EP2464346A1 (fr) 2010-08-30 2012-06-20 Pulmatrix, Inc. Méthodes de traitement de la mucoviscidose
DK2621488T3 (en) 2010-09-29 2019-03-04 Pulmatrix Operating Co Inc CATIONIC DRY POWDER
CN103228273B (zh) 2010-09-29 2017-04-05 普马特里克斯营业公司 吸入用单价金属阳离子干粉剂
EP2694220B1 (fr) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Appareil médical pourvu d'un récipient
PL3097915T3 (pl) * 2011-05-03 2024-05-20 Chiesi Farmaceutici S.P.A. Ulepszony preparat zawiesinowy kortykosteroidu do podawania poprzez inhalację
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
CA2865972C (fr) 2012-02-29 2022-01-04 Pulmatrix, Inc. Poudres seches pouvant etre inhalees
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2493827C1 (ru) * 2012-10-03 2013-09-27 Шолекс Девелопмент Гмбх Стабильный комбинированный раствор фенотерола гидробромида и ипратропия бромида
CA2907566C (fr) 2013-04-01 2023-08-22 Pulmatrix, Inc. Poudres seches de tiotropium
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
EP3030298B1 (fr) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nébuliseur
WO2015065223A1 (fr) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Solution stable de fénotérol bromhydrate
WO2015065219A1 (fr) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Solution de bromure d'ipratropium
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
RS64124B1 (sr) 2014-05-07 2023-05-31 Boehringer Ingelheim Int Inhalator i kontejner
DK3139984T3 (da) 2014-05-07 2021-07-19 Boehringer Ingelheim Int Forstøver
AU2016264961B2 (en) * 2015-05-18 2021-09-09 Glenmark Specialty S.A. Tiotropium inhalation solution for nebulization
CN109925300A (zh) * 2017-12-19 2019-06-25 北京盈科瑞创新药物研究有限公司 一种福多司坦雾化吸入用溶液制剂及其制备方法
CN115989032A (zh) 2020-07-31 2023-04-18 化学研究有限公司 用于吸入施用的组合疗法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
JPH0645538B2 (ja) * 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
GB8825892D0 (en) * 1988-11-04 1988-12-07 Fisons Plc Pharmaceutical composition
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE69030584T2 (de) * 1990-10-16 1997-09-04 Mayor Pharma Lab Inc Verfahren sowie zusammensetzungen zur behandlung mit vitaminmineral
AU6048694A (en) * 1992-12-09 1994-07-04 Paul D. Jager Stabilized medicinal aerosol solution formulations
TW431888B (en) * 1994-02-03 2001-05-01 Schering Plough Healthcare Nasal spray compositions
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
TR199701711T1 (xx) * 1995-06-27 1998-05-21 Boehringer Ingelheim Kg. Aerosollerin imalat� i�in yeni stabil ila� bile�imleri.
DE19536902A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19536916A1 (de) * 1995-10-04 1997-04-10 Boehringer Ingelheim Kg Inhalative Applikation von 2-Amino-6n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol, insbesondere seines (-)-Enantiomeren, sowie deren pharmakologisch verträgliche Säureadditionssalze
EP0808627A2 (fr) * 1996-05-22 1997-11-26 Hoechst Aktiengesellschaft Utilisation des antagonistes de la bradykinine non-peptidiques pour le traitement et la prévention des maladies de foie fibrotiques chroniques, des maladies de foie aigues et complications
DE19620509A1 (de) * 1996-05-22 1997-11-27 Hoechst Ag Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
DE19644646A1 (de) * 1996-10-26 1998-04-30 Mann & Hummel Filter Filter, insbesondere zur Filtrierung des Schmieröls einer Brennkraftmaschine
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
US20060239930A1 (en) * 1997-08-04 2006-10-26 Herbert Lamche Process for nebulizing aqueous compositions containing highly concentrated insulin
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20040019073A1 (en) * 2002-04-11 2004-01-29 Boehringer Ingelheim Pharma Gmbh Co. Kg Aerosol formulation for inhalation containing a tiotropium salt

Also Published As

Publication number Publication date
NO320652B1 (no) 2006-01-09
HU227012B1 (en) 2010-04-28
SI0946146T1 (en) 2003-10-31
EP1230916A2 (fr) 2002-08-14
YU28499A (sh) 2001-09-28
BG103482A (en) 2000-01-31
IL130464A0 (en) 2000-06-01
CA2275392A1 (fr) 1998-07-02
WO1998027959A2 (fr) 1998-07-02
CO4920211A1 (es) 2000-05-29
ZA9711370B (en) 1998-06-22
EP0946146B1 (fr) 2003-04-02
MY124547A (en) 2006-06-30
DE59709722D1 (de) 2003-05-08
NO993004D0 (no) 1999-06-18
KR20000057683A (ko) 2000-09-25
BR9713596B1 (pt) 2013-01-08
AU5663698A (en) 1998-07-17
RU2219906C2 (ru) 2003-12-27
PE32899A1 (es) 1999-04-23
AU740543B2 (en) 2001-11-08
CN1097455C (zh) 2003-01-01
NO993004L (no) 1999-06-18
BR9713596B8 (pt) 2013-02-19
US20090099225A1 (en) 2009-04-16
HUP0000520A2 (hu) 2000-09-28
ID22481A (id) 1999-10-21
WO1998027959A3 (fr) 1998-08-13
US20090185983A1 (en) 2009-07-23
EE03949B1 (et) 2003-02-17
AR008721A1 (es) 2000-02-09
ES2196388T3 (es) 2003-12-16
BRPI9713596C1 (pt) 2021-05-25
JP2001507343A (ja) 2001-06-05
SA97180756B1 (ar) 2006-04-28
HK1022846A1 (en) 2000-08-25
HRP970694B1 (en) 2005-06-30
DE19653969A1 (de) 1998-06-25
EP1230916A3 (fr) 2003-02-05
TW438605B (en) 2001-06-07
TR199901408T2 (xx) 1999-08-23
JP4659160B2 (ja) 2011-03-30
SK282910B6 (sk) 2003-01-09
BG64433B1 (en) 2005-02-28
HUP0000520A3 (en) 2000-10-30
EE9900307A (et) 2000-02-15
US20010008632A1 (en) 2001-07-19
KR100496723B1 (ko) 2005-06-22
UA64736C2 (uk) 2004-03-15
RS49803B (sr) 2008-06-05
UY24813A1 (es) 2000-09-29
BR9713596A (pt) 2000-04-04
NZ336825A (en) 2001-09-28
CA2275392C (fr) 2004-06-29
EG23981A (en) 2008-02-27
SK81499A3 (en) 2000-01-18
PL189511B1 (pl) 2005-08-31
HU0600044D0 (en) 2006-03-28
PL334185A1 (en) 2000-02-14
ATE235887T1 (de) 2003-04-15
HRP970694A2 (en) 1998-10-31
DK0946146T3 (da) 2003-04-22
HU228494B1 (en) 2013-03-28
CN1240347A (zh) 2000-01-05
PT946146E (pt) 2003-08-29
EP0946146A2 (fr) 1999-10-06

Similar Documents

Publication Publication Date Title
AU740543B2 (en) New aqueous medicament preparations for the production of propellent gas-free aerosols
US7470422B2 (en) Method for the production of propellant gas-free aerosols from aqueous medicament preparations
US6491897B1 (en) Stable pharmaceutical budesonide preparation for producing propellant-free aerosols
CZ222599A3 (cs) Farmaceutický prostředek
MXPA99005660A (en) New aqueous medicament preparations for the production of propellent gas-free aerosols
SA05260262B1 (ar) استخدام مستحضرات صيدلية لإنتاج ايروسولات خالية من المواد الداسرة (طلب جزئي)
AU3257000A (en) New, stable medicinal compositions for generating propellant-free aerosols

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired